RachnaShroffMDM.S.

Gastrointestinal Cancer

Chief, Division of Hematology/Oncology Associate Director, Clinical Investigations, University of Arizona Cancer Center (UACC) Associate Dean, Clinical and Translational Research, UA College of Medicine - Tucson Professor of Medicine

Join to view full profile

Dr. Shroff is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Shroff's full profile

Already have an account?

Office
3838 N Campbell Ave Unit 10
Tucson, AZ 85719
Phone+1 314-853-1185

Education & Training

University of Texas Health Science Center at Houston/M D Anderson Cancer CenterFellowship, Hematology and Medical Oncology, 2007 - 2010
Washington University/B-JH/SLCH ConsortiumResidency, Internal Medicine, 2004 - 2007
Sidney Kimmel Medical College at Thomas Jefferson UniversityClass of 2004

Certifications & Licensure

AZ State Medical License 2018 - 2025
TX State Medical License 2007 - 2024
American Board of Internal Medicine Medical Oncology

Clinical Trials

Atezolizumab + Cabozantinib in Patients w/ Metastatic, Refractory Pancreatic Cancer Start of enrollment: 2021 Oct 12
Recruiting
Phase 2
Roles: Principal Investigator, Contact
Immune Response to the COVID-19 Vaccine Start of enrollment: 2021 Jun 07
Completed
Early Phase 1
Gemcitabine and Cisplatin With or Without CPI-613 as First Line Therapy for Patients With Advanced Unresectable Biliary Tract Cancer (BilT-04) Start of enrollment: 2020 Jun 23
Active, not recruiting
Phase 1, Phase 2
Roles: Contact, Principal Investigator
Adaptive Approach to Neoadjuvant Therapy to Maximize Resection Rates for Pancreatic Adenocarcinoma Start of enrollment: 2021 Mar 17
Recruiting
Phase 2
Roles: Contact
Join now to see all

Publications & Presentations

PubMed

1 citations
A First-in-Human Study of Cinrebafusp Alfa, a HER2/4-1BB Bispecific Molecule, in Patients with HER2-Positive Advanced Solid Malignancies.
Sarina Piha-Paul, Shane A Olwill, Erika Hamilton, Anthony Tolcher, Paula Pohlmann
Clinical Cancer Research. 2025-01-17
Distinct molecular and clinical features of specific variants of KRAS codon 12 in pancreatic adenocarcinoma.
Bach Ardalan, Aaron Ciner, Yasmine Baca, Andrew Hinton, Sourat Darabi
Clinical Cancer Research. 2025-01-16
1 citations
SWOG S1815: A Phase III Randomized Trial of Gemcitabine, Cisplatin, and Nab-Paclitaxel Versus Gemcitabine and Cisplatin in Newly Diagnosed, Advanced Biliary Tract Canc...
Rachna T Shroff, Gentry King, Sarah Colby, Aaron J Scott, Mitesh J Borad
Journal of Clinical Oncology. 2024-12-13

Press Mentions

U of a Cancer Center’s Clinical Trial Pioneers New Advances in Biliary Tract Cancer TreatmentJanuary 16th, 2025
Miniature Organs Driving Precision Medicine and New Drug DiscoveryApril 21st, 2023
What Can Be Learned from Negative Findings of Two Trials in Biliary Tract CancerFebruary 7th, 2023
Join now to see all